BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cell Therapeutics, Inc. (CTIC) (CTI) Reschedules Third Quarter 2012 Financial Results to Thursday, November 1, 2012


10/30/2012 9:19:17 AM

SEATTLE, Oct. 29, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that due to severe weather on the East Coast of the United States related to Hurricane Sandy, CTI will now be releasing its financial results for the third quarter 2012 on Thursday, November 1, 2012, and will hold the related investor conference call the same day at 8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time. CTI had previously planned to announce its third quarter 2012 financial results on October 30, 2012.

Conference Call Numbers
Thursday, November 1
8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-941-2333 (US Participants)
1-480-629-9773 (International)
Call-back numbers for post-listening available at 11:30 a.m. Eastern:
1- 800-406-7325 (US Participants)
1- 303-590-3030 (International)
Passcode: 4572038 #
Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

Media Contact:

Investors Contact:



Dan Eramian

Ed Bell

T: 206.272.4343

T: 206.272.4345

C: 206.854.1200

E: invest@ctiseattle.com

F: 206.272.4434

www.celltherapeutics.com/investors

E: deramian@ctiseattle.com


www.celltherapeutics.com/press_room


SOURCE Cell Therapeutics, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->